These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 12806051

  • 21. Lipoxin receptors.
    Romano M, Recchia I, Recchiuti A.
    ScientificWorldJournal; 2007 Sep 01; 7():1393-412. PubMed ID: 17767357
    [Abstract] [Full Text] [Related]

  • 22. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
    Chiang N, Takano T, Clish CB, Petasis NA, Tai HH, Serhan CN.
    J Pharmacol Exp Ther; 1998 Nov 01; 287(2):779-90. PubMed ID: 9808710
    [Abstract] [Full Text] [Related]

  • 23. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN.
    Pharmacol Ther; 2005 Jan 01; 105(1):7-21. PubMed ID: 15626453
    [Abstract] [Full Text] [Related]

  • 24. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN.
    Arch Immunol Ther Exp (Warsz); 2001 Jan 01; 49(3):177-88. PubMed ID: 11478391
    [Abstract] [Full Text] [Related]

  • 25. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
    Pouliot M, Serhan CN.
    J Periodontal Res; 1999 Oct 01; 34(7):370-3. PubMed ID: 10685363
    [Abstract] [Full Text] [Related]

  • 26. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
    Wada K, Qiu FH, Stahl GL, Serhan CN.
    J Hematother Stem Cell Res; 2001 Feb 01; 10(1):75-9. PubMed ID: 11276361
    [Abstract] [Full Text] [Related]

  • 27. Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins.
    Romano M.
    Inflamm Allergy Drug Targets; 2006 Apr 01; 5(2):81-90. PubMed ID: 16613567
    [Abstract] [Full Text] [Related]

  • 28. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T, Clish CB, Gronert K, Petasis N, Serhan CN.
    J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977
    [Abstract] [Full Text] [Related]

  • 29. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG, Khreiss T, József L.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb 15; 73(3-4):257-62. PubMed ID: 15979865
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
    Clària J, Lee MH, Serhan CN.
    Mol Med; 1996 Sep 15; 2(5):583-96. PubMed ID: 8898374
    [Abstract] [Full Text] [Related]

  • 32. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.
    Guilford WJ, Parkinson JF.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Sep 15; 73(3-4):245-50. PubMed ID: 15985364
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation.
    Gewirtz AT, Fokin VV, Petasis NA, Serhan CN, Madara JL.
    Am J Physiol; 1999 Apr 15; 276(4):C988-94. PubMed ID: 10199831
    [Abstract] [Full Text] [Related]

  • 35. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells.
    Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, Fierro IM.
    Am J Physiol Cell Physiol; 2005 Sep 15; 289(3):C557-63. PubMed ID: 15901601
    [Abstract] [Full Text] [Related]

  • 36. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
    Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN.
    J Immunol; 2003 Jun 15; 170(12):6266-72. PubMed ID: 12794159
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
    Chiang N, Gronert K, Clish CB, O'Brien JA, Freeman MW, Serhan CN.
    J Clin Invest; 1999 Aug 15; 104(3):309-16. PubMed ID: 10430612
    [Abstract] [Full Text] [Related]

  • 39. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
    Gronert K, Gewirtz A, Madara JL, Serhan CN.
    J Exp Med; 1998 Apr 20; 187(8):1285-94. PubMed ID: 9547339
    [Abstract] [Full Text] [Related]

  • 40. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
    O'Meara YM, Brady HR.
    Kidney Int Suppl; 1997 Mar 20; 58():S56-61. PubMed ID: 9067945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.